Reducing Patients Anxiety by Making the Medicines More Available
The anxieties over the availability of the medications are rising after the new wave of sanctions against Iran imposed by the US in November 2018. Iranian patients are suffering from shortages and increasing prices of imported medications. Most of the foreign-made medications are used by patients diagnosed by life-risking diseases like cancer, multiple sclerosis and etc.
oranIT GmbH in cooperation with Darou Pakhsh Trade Promotion Company (DTPC), the biggest pharmaceutical group in Iran, providing solutions to lower the medications cost for the Iranian patients. By constantly monitoring the Iranian market, we find the demands and deliver the medications into Iran at the right time.
Our goal is by avoiding the dealer-chains, which are appearing due to unfair financial benefits during the sanction period, reduce the suffering and anxiety of the patients through their treatments.